Compositions Comprising Modified Erythropoietin

Full-text?

The full document isn't yet available to us from the patent office.

Abstract

Methods and compositions are provided for protecting or enhancing an erythropoietin-responsive cell, tissue, organ or body part function or viability in vivo, in situ or ex vivo in mammals, including human beings, by systemic or local administration of an erythropoietin receptor activity modulator, such as an erythropoietin or a modified erythropoietin.


Claims

Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Feb 9, 2011
  • Application: Dec 28, 2001
    EP EP 10012572 A
  • Priority: Dec 28, 2001
    EP EP 01987457 A
  • Priority: Dec 29, 2000
    US US 75313200 A
  • Priority: Dec 29, 2000
    US US 25924500 P

Download Citation


Sign in to the Lens

Feedback